相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Microscaled proteogenomic methods for precision oncology
Shankha Satpathy et al.
NATURE COMMUNICATIONS (2020)
PYCR1 promotes the progression of non-small-cell lung cancer under the negative regulation of miR-488
Dongchang Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
PD-1/PD-L1 Targeting in Breast Cancer: The First Clinical Evidences are Emerging-A Literature Review
Gabrielle Planes-Laine et al.
CANCERS (2019)
Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence
Michal Harel et al.
CELL (2019)
Immunotherapy in Triple-Negative Breast Cancer: Present and Future
Isaac Kim et al.
CURRENT BREAST CANCER REPORTS (2019)
Pyrroline-5-carboxylate reductase I promotes cell proliferation via inhibiting apoptosis in human malignant melanoma
Yingyi Ye et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
W. Fraser Symmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer
Tengyue Zeng et al.
MEDICAL ONCOLOGY (2017)
Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells
Ilaria Elia et al.
NATURE COMMUNICATIONS (2017)
Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers
Jiefeng Ding et al.
CARCINOGENESIS (2017)
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
Maya Dadiani et al.
CLINICAL CANCER RESEARCH (2016)
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading
Fabricio Loayza-Puch et al.
NATURE (2016)
Proteogenomics connects somatic mutations to signalling in breast cancer
Philipp Mertins et al.
NATURE (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
Proteomic maps of breast cancer subtypes
Stefka Tyanova et al.
NATURE COMMUNICATIONS (2016)
Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes A Meta-Analysis
Kristine R. Broglio et al.
JAMA ONCOLOGY (2016)
Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides
Wei Liu et al.
SCIENTIFIC REPORTS (2015)
Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again?
R. R. Saleh et al.
CURRENT ONCOLOGY (2014)
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
Patricia Cortazar et al.
LANCET (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy
J. Sohn et al.
ANNALS OF ONCOLOGY (2013)
DJ-1 cooperates with PYCR1 in cell protection against oxidative stress
Tatsuki Yasuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer?
A. Evans et al.
BRITISH JOURNAL OF CANCER (2013)
Mutations in PYCR1 gene in three families with autosomal recessive cutis laxa, type 2
D. Z. Scherrer et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Microscale oxygraphy reveals OXPHOS impairment in MRC mutant cells
F. Invernizzi et al.
MITOCHONDRION (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
Justin M. Balko et al.
NATURE MEDICINE (2012)
Functional Specialization in Proline Biosynthesis of Melanoma
Jessica De Ingeniis et al.
PLOS ONE (2012)
The proline regulatory axis and cancer
James Ming Phang et al.
FRONTIERS IN ONCOLOGY (2012)
Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts
Carsten Denkert et al.
BREAST CARE (2011)
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Juergen Cox et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: Current status
Victoria C. Hodgkinson et al.
CANCER LETTERS (2010)
Super-SILAC mix for quantitative proteomics of human tumor tissue
Tamar Geiger et al.
NATURE METHODS (2010)
Combination of FASP and StageTip-Based Fractionation Allows In-Depth Analysis of the Hippocampal Membrane Proteome
Jacek R. Wisniewski et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy
Valentina Guarneri et al.
ONCOLOGIST (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete Pathologic response after Neoadjuvant chemotherapy
Neal S. Goldstein et al.
CANCER (2007)
A general framework for weighted gene co-expression network analysis
Bin Zhang et al.
STATISTICAL APPLICATIONS IN GENETICS AND MOLECULAR BIOLOGY (2005)
Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach
JD Storey et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2004)
A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival
KN Ogston et al.
BREAST (2003)
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
JC Chang et al.
LANCET (2003)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics
J Rappsilber et al.
ANALYTICAL CHEMISTRY (2003)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
